Cetrorelix Patient Injection Training

Patient Injection Instructional video

V014 Rev 09/2022

Patient Injection Instructional guide

Before you inject Cetrorelix Acetate for Injection 0.25 mg yourself, please read the following instructions carefully.

Directions for using Cetrorelix with the enclosed needles and pre-filled syringe:
Cetrorelix Patient Injection Guide

Important Safety Information

Cetrorelix Acetate for Injection 0.25 mg (Cetrorelix) is indicated for the inhibition of premature LH surges in women undergoing controlled ovarian stimulation. Cetrorelix should be prescribed by physicians who are experienced in fertility treatment.

Cetrorelix is contraindicated in women who exhibit hypersensitivity to Cetrorelix, mannitol or medicines similar to Cetrorelix, who exhibit prior hypersensitivity to GnRH or any other GnRH analogs, or who are pregnant, are breast-feeding or have severe kidney disease.

Warnings and Precautions
Ovarian Hyperstimulation Syndrome (OHSS), with or without blood vessel or lung problems, can occur with the use of fertility drugs.

Adverse Reactions
Mild and short lasting injection reactions like reddening, itching and swelling at the injection sites may occur. Nausea and headache have also been reported.

Please click here for Full Prescribing Information.

MCS105 Rev 09/2022
The brand names mentioned are the trademarks of their respective owners.